Developer docs
API playgroundTry for free, no card

Search company profiles

Nuffield Council on Bioethics

Full company profile

uuid002khkv

Namestring
Nuffield Council on Bioethics
Legal namestring
Nuffield Council on Bioethics
Company typeenum
Private
Founded yearint
1991
Descriptiontext

The Nuffield Council on Bioethics (NCOB) is an independent non-profit policy and research centre founded in 1991 by the Nuffield Foundation, headquartered at 100 St John Street, London, with 11–50 staff. It identifies, analyses, and advises on ethical issues in biomedicine and health, delivering in-depth reports, policy briefings, annual Horizon Scans, and decision-support frameworks to UK Government departments, regulatory bodies (including the HFEA), the research community, and the general public. Its core products are not commercial software but policy methodologies and publications: the Rapid Ethics Assessment and Learning (REAL) method, an Ethical Lens for Horizon Scanning and Foresight, the Genomics Ethics Resources map, the Future of Ageing ethical framework, and the annual Horizon Scan portfolio.

The organisation does not develop proprietary technology; its core 'technology' is its deliberative methodology, combining working groups, expert panels (e.g., the Horizon Scanning Advisory Group), public engagement (Citizens' Summits, Community Conversations), and academic secondments. Revenue is grant and foundation funding rather than commercial sales: the Nuffield Foundation is the founding and co-funding parent, with additional project-specific grants from Wellcome (14-day rule review), UKRI Sciencewise (public dialogue), ARIA (Synthetic Plants), and the Office for Life Sciences (genomics ethics). Outputs are distributed free of charge via the website, newsletter, direct engagement, international networks (e.g., ISSCR), and at parliamentary and scientific committee presentations. NCOB operates under a 2024–2029 'Making Ethics Matter' strategy focused on three priority areas: reproduction, parenthood and families; the mind and brain; and the environment and health.

Short descriptiontext

The Nuffield Council on Bioethics is an independent UK non-profit founded in 1991 that produces bioethics research, policy briefings, and decision-support methodologies (e.g., the REAL method and annual Horizon Scans) for government, regulators, the research community, and the public.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioethics policy research, ethics advisory services, horizon scanning analysis, biomedical ethics guidance, policy research consulting
Industry2 codes
PRIMARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
NAICS code1 code
  • Other Similar Organizations (except Business, Professional, Labor, and Political Organizations)813990
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Bioethics Policy Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Charitable Foundation Funding
TypeProfessional Services
Description

The organization operates as a charitable initiative funded primarily by the Nuffield Foundation, which founded and co-funds the Council. Additional funding comes from Wellcome for specific projects such as the 14-day rule review, UKRI Sciencewise for public dialogue activities, and ARIA for the plant synthetic biology governance project.

nuffieldbioethics.org
2Project Grants and Partnerships
TypeProfessional Services
Description

The organization receives project-specific funding from government bodies and charitable foundations including the Office for Life Sciences for genomics ethics work and ARIA for synthetic biology governance initiatives.

nuffieldbioethics.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Nuffield Council on Bioethics is an independent policy and research centre that identifies, analyses, and advises on ethical issues in biomedicine and health. It produces in-depth reports, policy briefings, horizon scanning publications, and decision-support frameworks (such as the REAL method and Ethical Lens) for UK policymakers, regulators, and the research community. Its work is supported by deliberative public engagement including Citizens' Summits and community conversations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Work has led to lasting policy change in the UK and internationally over 35 years
+2 more records
Product overview1 text field

The Nuffield Council on Bioethics is an independent policy and research centre that identifies, analyses and advises on ethical issues in biomedicine and health. Rather than a commercial technology product, the Council offers a portfolio of policy research products and methodologies including: the Rapid Ethics Assessment and Learning (REAL) method for time-constrained policymaking; annual horizon scan publications with timeframe analysis; an ethical lens toolkit for horizon scanning and foresight; genomics ethics resource mapping; and an ethical framework for ageing research. These products are publications, frameworks, and decision-support tools aimed at policymakers, researchers, and public sector organisations rather than a software platform.

Product and service5 records
1Rapid Ethics Assessment and Learning (REAL) method
CategoryDecision-support framework
Description

A 5-stage pragmatic decision-support tool enabling policy professionals and institutions to quickly identify and address ethical challenges in time-pressured situations. The method includes one preparatory and four main stages, designed to recognise ethical tensions, clarify trade-offs and strengthen decision legitimacy.

2Horizon Scan Publications
CategoryResearch publication
Description

Annual horizon scanning publications that identify developments in biomedicine and health that may raise ethical implications, now presented with timeframe analysis for short-, medium-, and long-term impact.

3Ethical Lens for Horizon Scanning and Foresight
CategoryDecision-support framework
Description

A policy-tailored ethical lens for horizon scanning and foresight that enables decision-makers to bring ethical consideration into policy development processes. Includes three approaches: rapid ethical assessment tool, ethically sensitive sandbox, and moral deliberative tool.

4Genomics Ethics Resources
CategoryResearch publication
Description

Comprehensive UK map of publicly available ethics resources aimed at supporting the discovery, development and application of genomic technologies, covering consent, confidentiality, data governance, prenatal testing, and synthetic genomic data.

5Future of Ageing Ethical Framework and Toolkit
CategoryEthical toolkit
Description

An ethical toolkit in the form of prompts and questions to help researchers, practitioners and innovators think through ethical implications of research relating to living well in older age.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
1Faculty of Public Health
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Collaboration on development of Rapid Ethics Assessment and Learning (REAL) method. The Faculty of Public Health's Ethics Committee provided guidance and the Chair, Steven Bow, contributed to the development and launch of the REAL method for policymakers.

nuffieldbioethics.org
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-09
Description

Partnership to explore how a timeframe matrix prioritizing ethical implications can be applied to an international horizon scan for stem cell research. ISSCR represents nearly 5,000 scientists across 80+ countries.

3University of Edinburgh
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-02
Description

Lead partner in plant synthetic biology governance project. NCOB contributes horizon scanning and foresight expertise to co-design governance frameworks for synthetic plant genomics.

nuffieldbioethics.org
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Funding and partnership for public dialogue on 14-day rule for human embryo research. Sciencewise provides support for innovative and creative public engagement methods.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Delivering public dialogue on 14-day rule, including Citizens' Summit and Community Conversations. Partners with The Liminal Space and National Voices for design and community engagement.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Partnership for public dialogue delivery, identifying and recruiting participants from diverse communities and groups through charity networks.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Creative design partner for public dialogue, developing immersive and innovative approaches to engage participants with bioethics topics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-13
Description

Collaborative programme on genomics, neuroscience and education. The Nuffield Foundation founded and co-funds the NCOB and shares mission to advance educational opportunity and social well-being.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-01
Description

Partnership through the Ethics and Expertise (E&E) project, with Dr Marija Antanavičiūtė joining NCOB on 12-month secondment from the university to lead development of rapid ethical assessment tools.

10Office for Life Sciences
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-18
Description

Partnership on mapping ethics resources across genomic healthcare and research, funded and developed in partnership with OLS.

nuffieldbioethics.org
11Ada Lovelace Institute
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-09-01
Description

Joint project on AI and genomics futures investigating ethical issues arising from convergence of genomics and AI. Includes development of ethical lens for horizon scanning in collaboration with Federica Lucivero from Oxford.

nuffieldbioethics.org
12Scottish, Welsh, and Northern Irish Health Departments
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Partnership with genomics healthcare leads in Scotland, Wales, and Northern Ireland for establishing UK best practice approach for ethical standards in genomics research.

nuffieldbioethics.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight11 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Parent organization and primary funder of NCOB; an independent charitable trust funding research and policy work across education, justice, and welfare, including substantial bioethics-adjacent grantmaking. Directly comparable as a funder and convener, with much broader thematic scope.

2Centre for Bioethics, University of Oxford
TypeEmerging player
Description

Academic bioethics center producing scholarly research and policy advice on bioethical issues. Comparable as a UK-based source of bioethics analysis feeding into policy, but operating within an academic rather than independent-charitable model.

TypeOthers
Description

A UK-based academic-media outlet that commissions expert-authored articles on bioethical and health policy topics. Comparable as a public-facing channel for bioethics content, but operating as a journalistic platform rather than an independent research body.

TypeDirect peer
Description

A US-based independent bioethics research institute founded in 1969. Directly comparable as a long-standing, independent non-profit bioethics research organization that publishes reports, conducts public engagement, and influences health and biomedical policy.

TypeRegional player
Description

Ethics oversight body for the UK Biobank, providing independent ethics advice on a major UK biomedical research resource. Comparable as a UK-based independent ethics advisory function on biomedical research, with a narrower scope (one research infrastructure rather than multi-topic).

TypeBroad incumbent
Description

UK doctors' professional association with a substantial ethics department producing policy guidance on medical ethics topics. Comparable as a UK-based producer of biomedical ethics policy advice, but representing a professional membership constituency rather than an independent think tank.

TypeEmerging player
Description

International scientific society representing nearly 5,000 stem cell researchers across 80+ countries. Comparable as a partner and adjacent body in bioethics governance of regenerative medicine, with overlapping interests in horizon scanning and ethical frameworks for emerging science.

8Ada Lovelace Institute
TypeDirect peer
Description

An independent UK research institute focused on the ethical and societal implications of data and AI. Directly comparable as a UK-based independent non-profit conducting research, public engagement, and policy advisory work on emerging technology ethics, with overlapping funder base and government-facing policy role.

TypeBroad incumbent
Description

The intergovernmental body responsible for bioethics advice within UNESCO, producing declarations and reports on bioethical issues. Comparable as a bioethics advisory body that influences national and international policy, but operating at a much larger, global intergovernmental scale.

TypeBroad incumbent
Description

A major UK charitable foundation funding research on health, including substantial programs on ethics and society. Comparable as a UK-based charitable funder and producer of ethical analysis on biomedical topics, operating with broader scope than NCOB.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nuffield Council on Bioethics

Bioethics Policy Researchnuffieldbioethics.org

The Nuffield Council on Bioethics is an independent UK non-profit founded in 1991 that produces bioethics research, policy briefings, and decision-support methodologies (e.g., the REAL method and annual Horizon Scans) for government, regulators, the research community, and the public.

What Nuffield Council on Bioethics does

The Nuffield Council on Bioethics (NCOB) is an independent non-profit policy and research centre founded in 1991 by the Nuffield Foundation, headquartered at 100 St John Street, London, with 11–50 staff. It identifies, analyses, and advises on ethical issues in biomedicine and health, delivering in-depth reports, policy briefings, annual Horizon Scans, and decision-support frameworks to UK Government departments, regulatory bodies (including the HFEA), the research community, and the general public. Its core products are not commercial software but policy methodologies and publications: the Rapid Ethics Assessment and Learning (REAL) method, an Ethical Lens for Horizon Scanning and Foresight, the Genomics Ethics Resources map, the Future of Ageing ethical framework, and the annual Horizon Scan portfolio.

The organisation does not develop proprietary technology; its core 'technology' is its deliberative methodology, combining working groups, expert panels (e.g., the Horizon Scanning Advisory Group), public engagement (Citizens' Summits, Community Conversations), and academic secondments. Revenue is grant and foundation funding rather than commercial sales: the Nuffield Foundation is the founding and co-funding parent, with additional project-specific grants from Wellcome (14-day rule review), UKRI Sciencewise (public dialogue), ARIA (Synthetic Plants), and the Office for Life Sciences (genomics ethics). Outputs are distributed free of charge via the website, newsletter, direct engagement, international networks (e.g., ISSCR), and at parliamentary and scientific committee presentations. NCOB operates under a 2024–2029 'Making Ethics Matter' strategy focused on three priority areas: reproduction, parenthood and families; the mind and brain; and the environment and health.

Nuffield Council on Bioethics firmographics

Firmographics
Name
Nuffield Council on Bioethics
Legal name
Nuffield Council on Bioethics
Website
https://nuffieldbioethics.org
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
11–50 employees
Short description
The Nuffield Council on Bioethics is an independent UK non-profit founded in 1991 that produces bioethics research, policy briefings, and decision-support methodologies (e.g., the REAL method and annual Horizon Scans) for government, regulators, the research community, and the public.
Ownership category
akta.pro rank

Nuffield Council on Bioethics industry classification

Industry
Product category
Bioethics Policy Research
NAICS
Other Similar Organizations (except Business, Professional, Labor, and Political Organizations) (813990)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities

Keywords

  • Bioethics policy research
  • Ethics advisory services
  • Horizon scanning analysis
  • Biomedical ethics guidance
  • Policy research consulting

Where Nuffield Council on Bioethics is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Nuffield Council on Bioethics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Charitable Foundation Funding: The organization operates as a charitable initiative funded primarily by the Nuffield Foundation, which founded and co-funds the Council. Additional funding comes from Wellcome for specific projects such as the 14-day rule review, UKRI Sciencewise for public dialogue activities, and ARIA for the plant synthetic biology governance project.
  2. Project Grants and Partnerships: The organization receives project-specific funding from government bodies and charitable foundations including the Office for Life Sciences for genomics ethics work and ARIA for synthetic biology governance initiatives.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Nuffield Council on Bioethics product offering

Product offering

Core offering

The Nuffield Council on Bioethics is an independent policy and research centre that identifies, analyses, and advises on ethical issues in biomedicine and health. It produces in-depth reports, policy briefings, horizon scanning publications, and decision-support frameworks (such as the REAL method and Ethical Lens) for UK policymakers, regulators, and the research community. Its work is supported by deliberative public engagement including Citizens' Summits and community conversations.

Product overview

The Nuffield Council on Bioethics is an independent policy and research centre that identifies, analyses and advises on ethical issues in biomedicine and health. Rather than a commercial technology product, the Council offers a portfolio of policy research products and methodologies including: the Rapid Ethics Assessment and Learning (REAL) method for time-constrained policymaking; annual horizon scan publications with timeframe analysis; an ethical lens toolkit for horizon scanning and foresight; genomics ethics resource mapping; and an ethical framework for ageing research. These products are publications, frameworks, and decision-support tools aimed at policymakers, researchers, and public sector organisations rather than a software platform.

Differentiator

Problem solved

Functional benefit

Products and services

  • Rapid Ethics Assessment and Learning (REAL) method A 5-stage pragmatic decision-support tool enabling policy professionals and institutions to quickly identify and address ethical challenges in time-pressured situations. The method includes one preparatory and four main stages, designed to recognise ethical tensions, clarify trade-offs and strengthen decision legitimacy.
  • Horizon Scan Publications Annual horizon scanning publications that identify developments in biomedicine and health that may raise ethical implications, now presented with timeframe analysis for short-, medium-, and long-term impact.
  • Ethical Lens for Horizon Scanning and Foresight A policy-tailored ethical lens for horizon scanning and foresight that enables decision-makers to bring ethical consideration into policy development processes. Includes three approaches: rapid ethical assessment tool, ethically sensitive sandbox, and moral deliberative tool.
  • Genomics Ethics Resources Comprehensive UK map of publicly available ethics resources aimed at supporting the discovery, development and application of genomic technologies, covering consent, confidentiality, data governance, prenatal testing, and synthetic genomic data.
  • Future of Ageing Ethical Framework and Toolkit An ethical toolkit in the form of prompts and questions to help researchers, practitioners and innovators think through ethical implications of research relating to living well in older age.

Quantifiable outcome

  • Work has led to lasting policy change in the UK and internationally over 35 years
  • +2 more outcomes

Companies that use Nuffield Council on Bioethics

Customer profile

Segments4 records

Ideal customer profiles3 records

Nuffield Council on Bioethics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Nuffield Council on Bioethics partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • Faculty of Public HealthcoreStrategic or Co-development Partner · 9 June 2026Collaboration on development of Rapid Ethics Assessment and Learning (REAL) method. The Faculty of Public Health's Ethics Committee provided guidance and the Chair, Steven Bow, contributed to the development and launch of the REAL method for policymakers.
  • International Society for Stem Cell Research (ISSCR)coreStrategic or Co-development Partner · 9 September 2025Partnership to explore how a timeframe matrix prioritizing ethical implications can be applied to an international horizon scan for stem cell research. ISSCR represents nearly 5,000 scientists across 80+ countries.
  • University of EdinburghcoreStrategic or Co-development Partner · 2 June 2025Lead partner in plant synthetic biology governance project. NCOB contributes horizon scanning and foresight expertise to co-design governance frameworks for synthetic plant genomics.
  • UKRI SciencewisecoreStrategic or Co-development Partner · 21 May 2025Funding and partnership for public dialogue on 14-day rule for human embryo research. Sciencewise provides support for innovative and creative public engagement methods.
  • Ipsos UKcoreStrategic or Co-development Partner · 21 May 2025Delivering public dialogue on 14-day rule, including Citizens' Summit and Community Conversations. Partners with The Liminal Space and National Voices for design and community engagement.
  • National VoicescoreStrategic or Co-development Partner · 21 May 2025Partnership for public dialogue delivery, identifying and recruiting participants from diverse communities and groups through charity networks.
  • The Liminal SpacecoreStrategic or Co-development Partner · 21 May 2025Creative design partner for public dialogue, developing immersive and innovative approaches to engage participants with bioethics topics.
  • Nuffield FoundationcoreStrategic or Co-development Partner · 13 February 2025Collaborative programme on genomics, neuroscience and education. The Nuffield Foundation founded and co-funds the NCOB and shares mission to advance educational opportunity and social well-being.
  • University of BirminghamcoreStrategic or Co-development Partner · 1 September 2024Partnership through the Ethics and Expertise (E&E) project, with Dr Marija Antanavičiūtė joining NCOB on 12-month secondment from the university to lead development of rapid ethical assessment tools.
  • Office for Life SciencescoreStrategic or Co-development Partner · 18 January 2024Partnership on mapping ethics resources across genomic healthcare and research, funded and developed in partnership with OLS.
  • Ada Lovelace InstitutecoreStrategic or Co-development Partner · 1 September 2023Joint project on AI and genomics futures investigating ethical issues arising from convergence of genomics and AI. Includes development of ethical lens for horizon scanning in collaboration with Federica Lucivero from Oxford.
  • Scottish, Welsh, and Northern Irish Health DepartmentsminorStrategic or Co-development Partner · 1 January 2022Partnership with genomics healthcare leads in Scotland, Wales, and Northern Ireland for establishing UK best practice approach for ethical standards in genomics research.

Scale indicators6 records

Recent moves6 records

Expansion highlights11 records

Nuffield Council on Bioethics competitors and assessment

Company assessment

Broad incumbents

  • Nuffield Foundation: Parent organization and primary funder of NCOB; an independent charitable trust funding research and policy work across education, justice, and welfare, including substantial bioethics-adjacent grantmaking. Directly comparable as a funder and convener, with much broader thematic scope.
  • British Medical Association (BMA) Ethics Department: UK doctors' professional association with a substantial ethics department producing policy guidance on medical ethics topics. Comparable as a UK-based producer of biomedical ethics policy advice, but representing a professional membership constituency rather than an independent think tank.
  • UNESCO International Bioethics Committee (IBC): The intergovernmental body responsible for bioethics advice within UNESCO, producing declarations and reports on bioethical issues. Comparable as a bioethics advisory body that influences national and international policy, but operating at a much larger, global intergovernmental scale.
  • Wellcome Trust (Ethics & Society): A major UK charitable foundation funding research on health, including substantial programs on ethics and society. Comparable as a UK-based charitable funder and producer of ethical analysis on biomedical topics, operating with broader scope than NCOB.

Emerging players

  • Centre for Bioethics, University of Oxford: Academic bioethics center producing scholarly research and policy advice on bioethical issues. Comparable as a UK-based source of bioethics analysis feeding into policy, but operating within an academic rather than independent-charitable model.
  • International Society for Stem Cell Research (ISSCR): International scientific society representing nearly 5,000 stem cell researchers across 80+ countries. Comparable as a partner and adjacent body in bioethics governance of regenerative medicine, with overlapping interests in horizon scanning and ethical frameworks for emerging science.

Others

  • The Conversation (Ethics & Health sections): A UK-based academic-media outlet that commissions expert-authored articles on bioethical and health policy topics. Comparable as a public-facing channel for bioethics content, but operating as a journalistic platform rather than an independent research body.

Direct peers

  • The Hastings Center: A US-based independent bioethics research institute founded in 1969. Directly comparable as a long-standing, independent non-profit bioethics research organization that publishes reports, conducts public engagement, and influences health and biomedical policy.
  • Ada Lovelace Institute: An independent UK research institute focused on the ethical and societal implications of data and AI. Directly comparable as a UK-based independent non-profit conducting research, public engagement, and policy advisory work on emerging technology ethics, with overlapping funder base and government-facing policy role.

Regional players

  • UK Biobank Ethics Advisory Committee: Ethics oversight body for the UK Biobank, providing independent ethics advice on a major UK biomedical research resource. Comparable as a UK-based independent ethics advisory function on biomedical research, with a narrower scope (one research infrastructure rather than multi-topic).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Nuffield Council on Bioethics social profiles

Digital presence

Nuffield Council on Bioethics compliance and trust

Trust signal

Compliance1 record

Nuffield Council on Bioethics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nuffield Council on Bioethics leadership team

Management profile

Number of profiles

Profiles10 records

Nuffield Council on Bioethics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nuffield Council on Bioethics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nuffield Council on Bioethics

What does Nuffield Council on Bioethics do?

The Nuffield Council on Bioethics is an independent policy and research centre that identifies, analyses, and advises on ethical issues in biomedicine and health. It produces in-depth reports, policy briefings, horizon scanning publications, and decision-support frameworks (such as the REAL method and Ethical Lens) for UK policymakers, regulators, and the research community. Its work is supported by deliberative public engagement including Citizens' Summits and community conversations.

Is Nuffield Council on Bioethics a public or private company?

Nuffield Council on Bioethics is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Nuffield Council on Bioethics founded?

Nuffield Council on Bioethics was founded in 1991. It employs 11 to 50 people.

Where is Nuffield Council on Bioethics based?

Nuffield Council on Bioethics is headquartered in London, United Kingdom, in the Europe region.

How does Nuffield Council on Bioethics make money?

Two revenue lines are on record. Charitable Foundation Funding is the primary driver. The others are project Grants and Partnerships.

Who are Nuffield Council on Bioethics's main competitors?

Broad incumbents on record are Nuffield Foundation, British Medical Association (BMA) Ethics Department, UNESCO International Bioethics Committee (IBC) and Wellcome Trust (Ethics & Society). Emerging players are Centre for Bioethics, University of Oxford and International Society for Stem Cell Research (ISSCR). The Conversation (Ethics & Health sections) is listed as an others. Direct peers are The Hastings Center and Ada Lovelace Institute. UK Biobank Ethics Advisory Committee is listed as a regional player.

Does Nuffield Council on Bioethics have an API?

No public API is recorded for Nuffield Council on Bioethics.

What industry is Nuffield Council on Bioethics in?

Nuffield Council on Bioethics's product category is Bioethics Policy Research. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations, with a secondary code of HLAJACAG, Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight). Its NAICS code is 813990 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WeforumShould we be allowed to edit the genes of human embryos?The UK’s Nuffield Council on Bioethics stated that gene editing of human embryos could be morally permissible under strict ethical guidelines, though current laws prohibiting the practice should remain in place. The panel urged scientists and governments globally to engage in early public debate regarding the implications of technologies like CRISPR/Cas9 for future reproductive choices.News and jobs from the chemicalIs AI a ‘Ghost in the Machine’?IChemE is incorporating AI risk guidance into all its published contracts, prompted by the Bar Council's 2024 warning that AI-generated legal submissions had collapsed under scrutiny and by broader concerns about the lack of robust validation methods for AI systems in engineering projects. The institution consulted legal experts including Paul Buckingham KC and sought external input from the Nuffield Bioethics Committee, with the guidance set to address disclosure requirements, system validation challenges, and ethical considerations around AI use in engineering. While highlighting AI's potential benefits such as MIT's deep learning antibiotic discovery, the article argues that professional integrity and corporate governance must fill the current regulatory gap since AI will not regulate itself.BBCRules to create gene-edited farm animals must put welfare first - reviewAn independent review by the Nuffield Council for Bioethics urges that regulations for gene-edited farm animals must prioritize welfare. It warns that scrapping the current ban could increase livestock suffering and recommends a government review and public consultation. The UK government is considering new rules to allow commercial development of gene-edited livestock in England.Business InsiderGenetically modified 'designer babies' might be okay, according to a top ethics councilThe Nuffield Council on Bioethics released a report saying genetic editing of human embryos could be ethically acceptable under certain conditions. It requires edits to prioritize the welfare of the child and avoid increasing inequality. The report urges establishing an ethical framework now as the technology approaches feasibility.The BMJHuman genome editing is not unethical, says Nuffield CouncilThe Nuffield Council for Bioethics concluded that germline genome editing is not unethical if it passes preconditions, including contributing to the welfare of the person born and not increasing risks. The report does not restrict the technique to therapeutic uses.BBCEditing human embryos 'morally permissible'The Nuffield Council of Bioethics concluded there is no absolute reason against editing human embryos, but it must be regulated. The inquiry calls for further medical and social research, with heritable genome editing potentially feasible in up to 20 years.News-MedicalBriefing note examines ethical issues in whole genome sequencing of babiesThe Nuffield Council on Bioethics published a briefing note examining ethical issues of whole genome sequencing of babies, noting its use in NHS care for seriously ill infants and potential commercial availability. The note highlights uncertainties about sharing results, storage, and access, and calls for public consideration. It also notes ongoing debate about expanding NHS newborn screening.The BMJCosmetic industry regulation is only skin deepThe Nuffield Council on Bioethics launched a report on cosmetic procedures, citing the lack of statutory controls over practitioner qualifications. It calls for urgent legislation to protect the public, noting the industry's value grew from £750m in 2005 to £3.16bn in 2015.The BMJControls on cosmetic treatments are “completely inadequate,” report warnsA Nuffield Council on Bioethics report urged compulsory registration for cosmetic surgeons, citing industry growth from £750m in 2005 to £3.16bn in 2015. The report calls for more government action to protect the public from the cosmetic treatments industry.BBCGovernment approves new Down's syndrome testThe UK government approved a new non-invasive prenatal test for Down's syndrome, to be rolled out by the NHS from 2018. The test could avoid over 6,000 invasive amniocentesis procedures annually, reducing related miscarriages from 46 to about three per year. Critics worry it may lead to more abortions, and the Nuffield Council on Bioethics will review ethical issues in early 2017.